Stock Market Review 28AUG23 #shorts

Decoding schizophrenia: insights and impacts from genetic discoveries

A recent study in Molecular Psychiatry delves into the genetic architecture of schizophrenia, uncovering insights into common and rare genetic variants, treatment resistance, and the

October 22, 2023

Bayer lowers full-year outlook – Biotech Investments

Bayer Aktiengesellschaft / Key word(s): Change in Forecast Bayer Aktiengesellschaft: Bayer lowers full-year outlook 24-Jul-2023 / 19:32 CET/CEST Disclosure of an inside information acc. to

July 25, 2023

Infectious disease biotech halts late-stage trial due to subpar efficacy, shares plummet 70%

Enrollment for a late-stage trial by California biotech AN2 Therapeutics that was testing its lead drug candidate for Mycobacterium avium complex (MAC) lung disease was

February 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.